News Archives

  • New York Times

    August 31st, 2018

    A Little-Known Windfall for Some Hospitals, Now Facing Big Cuts — opinion by Austin Frakt, associate professor of health law, policy & management

  • WSAU

    July 18th, 2018

    Evidence to Support ‘Breakthrough’ Drugs Often Very Limited: Study — quotes Austin Frakt, associate professor of health law, policy & management

  • MedShadow

    July 18th, 2018

    Drugs Approved More Quickly Have Less Robust Clinical Trials — quotes Austin Frakt, associate professor of health law, policy & management

  • Tracking Scope and Impact of Pharmaceutical Companies’ Social Investment

    July 16th, 2018

    Richard Laing, Peter Rockers, and Veronika Wirtz publish inaugural report of Access Observatory, which tracks pharmaceutical companies’ contributions to disease prevention and treatment.

  • Mapping Kenya’s Clinical Trial Landscape

    June 28th, 2018

    Practicum student Kofi Addo works with Pharmacy & Poisons Board to analyze trends in clinical trials conducted in Kenya.

  • Access to Insulin Limited in Nepal

    April 5th, 2018

    Country suffers from high burden of type 2 diabetes, affecting as much as 19 percent of population.

  • Townhall

    February 14th, 2018

    Foreign Freeloading to Blame for High Drug Prices — quotes Austin Frakt, associate professor of health law, policy & management

  • Slate

    December 11th, 2017

    The CVS–Aetna Merger Will Be a Disaster for Small Drugstores — quotes Austin Frakt, associate professor of health law, policy & management

  • New York Times

    December 4th, 2017

    Why a CVS-Aetna Merger Could Benefit Consumers — opinion by Austin Frakt, associate professor of health law, policy & management

  • The Indian Express

    September 5th, 2017

    India-Nepal Blockade Led to 46.5% Dip in Retail Trade of Medicines: Study — mentions Warren Kaplan, clinical assistant professor of